Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    pcI-27483
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Conditions: Pancreatic Cancer;   Ductal Adrenocarcinoma;   Exocrine Pancreatic Cancer
Interventions: Drug: PCI-27483;   Drug: Gemcitabine

Indicates status has not been verified in more than two years